WASHINGTON (Reuters) - Republicans on a congressional panel investigating a deadly meningitis outbreak linked to tainted drugs have told the top U.S. drug regulator not to expect new authority to prevent future problems until the agency hands over documents about its role in the current crisis.




Source: House Republicans to FDA: no meningitis action without documents


David Cottle

UBB Owner & Administrator